Curcumin and diabetes: A systematic review

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Zhang, Dong Wei ^a   Fu, Min ^b   Gao, Si Hua ^a   Liu, Jun Li ^b  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893776310     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/636053     Document Type: Review

References (185)

1. Shapiro K., Gong W. C., Natural products used for diabetes. Journal of the American Pharmaceutical Association 2002 42 2 217 226 2-s2.0-0036517205
2. Gobert C. P., Duncan A. M., Consumption, perceptions and knowledge of soy among adults with type 2 diabetes. Journal of the American College of Nutrition 2009 28 2 203 218 2-s2.0-74049133357
3. Jiang C. S., Liang L. F., Guo Y. W., Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades. Acta Pharmacologica Sinica 2012 33 10 1217 1245
4. Nolan C. J., Damm P., Prentki M., Type 2 diabetes across generations: from pathophysiology to prevention and management. The Lancet 2011 378 9786 169 181 2-s2.0-79960202841 10.1016/S0140-6736(11)60614-4
5. Aggarwal B. B., Sundaram C., Malani N., Ichikawa H., Curcumin: the Indian solid gold. Advances in Experimental Medicine and Biology 2007 595 1 75 2-s2.0-34347246346 10.1007/978-0-387-46401-5-1
6. Kolev T. M., Velcheva E. A., Stamboliyska B. A., Spiteller M., DFT and experimental studies of the structure and vibrational spectra of curcumin. International Journal of Quantum Chemistry 2005 102 6 1069 1079 2-s2.0-17644413797 10.1002/qua.20469 (Pubitemid 40566988)
7. Perez-Torres I., Ruiz-Ramirez A., Banos G., El-Hafidi M., Hibiscus sabdariffa Linnaeus (Malvaceae), curcumin and resveratrol as alternative medicinal agents against metabolic syndrome. Cardiovascular & Hematological Agents in Medicinal Chemistry 2013 11 1 25 37
8. Goel A., Kunnumakkara A. B., Aggarwal B. B., Curcumin as "Curecumin": from kitchen to clinic. Biochemical Pharmacology 2008 75 4 787 809 2-s2.0-38749109673 10.1016/j.bcp.2007.08.016 (Pubitemid 351181424)
9. Shehzad A., Ha T., Subhan F., Lee Y. S., New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. European Journal of Nutrition 2011 50 3 151 161 2-s2.0-79959228675 10.1007/s00394-011-0188-1
10. Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S., Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012 35 11 2121 2127
11. Aggarwal B. B., Kumar A., Bharti A. C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Research 2003 23 1 A 363 398 2-s2.0-0037236792 (Pubitemid 36361976)
12. Srinivasan M., Effect of curcumin on blood sugar as seen in a diabetic subject. Indian Journal of Medical Sciences 1972 26 4 269 270 2-s2.0-0015319846
13. Sahebkar A., Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors 2013 39 2 197 208
14. Pari L., Murugan P., Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. Journal of Medicinal Food 2007 10 2 323 329 2-s2.0-34547106585 10.1089/jmf.2006.058 (Pubitemid 47105678)
15. Arun N., Nalini N., Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods for Human Nutrition 2002 57 1 41 52 2-s2.0-0036007614 10.1023/A:1013106527829 (Pubitemid 34128408)
16. Murugan P., Pari L., Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats. Basic and Clinical Pharmacology and Toxicology 2007 101 4 241 245 2-s2.0-36649036000 10.1111/j.1742-7843.2007.00109.x (Pubitemid 350194802)
17. Peeyush K. T., Gireesh G., Jobin M., Paulose C. S., Neuroprotective role of curcumin in the cerebellum of streptozotocin-induced diabetic rats. Life Sciences 2009 85 19-20 704 710 2-s2.0-70350331099 10.1016/j.lfs.2009.09.012
18. 3 and curcumin. European Journal of Pharmacology 2012 687 1-3 14 20 10.1016/j.ejphar.2012.02.050
19. Na L.-X., Zhang Y.-L., Li Y., Liu L.-Y., Li R., Kong T., Sun C.-H., Curcumin improves insulin resistance in skeletal muscle of rats. Nutrition, Metabolism and Cardiovascular Diseases 2011 21 7 526 533 2-s2.0-79959508832 10.1016/j.numecd.2009.11.009
20. Patumraj S., Wongeakin N., Sridulyakul P., Jariyapongskul A., Futrakul N., Bunnag S., Combined effects of curcumin and vitamin C to protect endothelial dysfunction in the iris tissue of STZ-induced diabetic rats. Clinical Hemorheology and Microcirculation 2006 35 4 481 489 2-s2.0-33751357523 (Pubitemid 44812461)
21. Soetikno V., Sari F. R., Veeraveedu P. T., Thandavarayan R. A., Harima M., Sukumaran V., Lakshmanan A. P., Suzuki K., Kawachi H., Watanabe K., Curcumin ameliorates macrophage infiltration by inhibiting NF-B activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutrition & Metabolism 2011 8, article 35 2-s2.0-79958151875 10.1186/1743-7075-8-35
22. Jain S. K., Rains J., Croad J., Larson B., Jones K., Curcumin supplementation lowers TNF- α IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF- α IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxidants and Redox Signaling 2009 11 2 241 249 2-s2.0-58149090424 10.1089/ars.2008.2140
23. Soetikno V., Watanabe K., Sari F. R., Harima M., Thandavarayan R. A., Veeraveedu P. T., Arozal W., Sukumaran V., Lakshmanan A. P., Arumugam S., Suzuki K., Curcumin attenuates diabetic nephropathy by inhibiting PKC- α and PKC- β 1 activity in streptozotocin-induced type I diabetic rats. Molecular Nutrition and Food Research 2011 55 11 1655 1665 2-s2.0-80155194979 10.1002/mnfr.201100080
24. Ali Hussain H. E. M., Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn, and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes. Indian Journal of Clinical Biochemistry 2002 17 2 33 43 2-s2.0-0041906491
25. Mahesh T., Sri Balasubashini M. M., Menon V. P., Photo-irradiated curcumin supplementation in streptozotocin-induced diabetic rats: effect on lipid peroxidation. Therapie 2004 59 6 639 644 2-s2.0-14844362006 10.2515/therapie:2004110 (Pubitemid 40353969)
26. El-Moselhy M. A., Taye A., Sharkawi S. S., El-Sisi S. F. I., Ahmed A. F., The antihyperglycemic effect of curcumin in high fat diet fed rats. Role of TNF- α and free fatty acids. Food and Chemical Toxicology 2011 49 5 1129 1140 2-s2.0-79953030266 10.1016/j.fct.2011.02.004
27. Chougala M. B., Bhaskar J. J., Rajan M. G. R., Salimath P. V., Effect of curcumin and quercetin on lysosomal enzyme activities in streptozotocin-induced diabetic rats. Clinical Nutrition 2012 31 5 749 755 2-s2.0-84858742556 10.1016/j.clnu.2012.02.003
28. Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., Kitahara M., Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) Suppress an increase in blood glucose level in type 2 diabetic KK-A γ mice. Journal of Agricultural and Food Chemistry 2005 53 4 959 963 2-s2.0-13944267830 10.1021/jf0483873 (Pubitemid 40270383)
29. Weisberg S. P., Leibel R., Tortoriello D. V., Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 2008 149 7 3549 3558 2-s2.0-46349088791 10.1210/en.2008-0262 (Pubitemid 351919581)
30. Seo K.-I., Choi M.-S., Jung U. J., Kim H.-J., Yeo J., Jeon S.-M., Lee M.-K., Effect of curcumin supplementation on blood glucose, plasma insulin, and glucose homeostasis related enzyme activities in diabetic db/db mice. Molecular Nutrition and Food Research 2008 52 9 995 1004 2-s2.0-54949119528 10.1002/mnfr.200700184
31. Yousef M. I., El-Demerdash F. M., Radwan F. M. E., Sodium arsenite induced biochemical perturbations in rats: ameliorating effect of curcumin. Food and Chemical Toxicology 2008 46 11 3506 3511 2-s2.0-54849434174 10.1016/j.fct.2008.08.031
32. El-Azab M. F., Attia F. M., El-Mowafy A. M., Novel role of curcumin combined with bone marrow transplantation in reversing experimental diabetes: effects on pancreatic islet regeneration, oxidative stress, and inflammatory cytokines. European Journal of Pharmacology 2011 658 1 41 48 2-s2.0-79952817657 10.1016/j.ejphar.2011.02.010
33. He H. J., Wang G. Y., Gao Y., Ling W. H., Yu Z. W., Jin T. R., Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World Journal of Diabetes 2012 3 5 94 104
34. Suryanarayana P., Satyanarayana A., Balakrishna N., Kumar P. U., Bhanuprakash Reddy G., Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat. Medical Science Monitor 2007 13 12 BR286 BR292 2-s2.0-37249074345 (Pubitemid 350272876)
35. Murugan P., Pari L., Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats. Journal of Ethnopharmacology 2007 113 3 479 486 2-s2.0-34548423141 10.1016/j.jep.2007.07.004 (Pubitemid 47361566)
36. Gutierres V. O., Pinheiro C. M., Assis R. P., Vendramini R. C., Pepato M. T., Brunetti I. L., Curcumin-supplemented yoghurt improves physiological and biochemical markers of experimental diabetes. The British Journal of Nutrition 2012 108 3 440 448
37. Nishizono S., Hayami T., Ikeda I., Imaizumi K., Protection against the diabetogenic effect of feeding tert-butylhydroquinone to rats prior to the administration of streptozotocin. Bioscience, Biotechnology and Biochemistry 2000 64 6 1153 1158 2-s2.0-0034203504
38. Majithiya J. B., Balaraman R., Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. Journal of Cardiovascular Pharmacology 2005 46 5 697 705 2-s2.0-27344449941 10.1097/01.fjc.0000183720.85014.24 (Pubitemid 41527764)
39. Prentki M., Madiraju S. R. M., Glycerolipid metabolism and signaling in health and disease. Endocrine Reviews 2008 29 6 647 676 2-s2.0-53049094467 10.1210/er.2008-0007
40. Babu P. S., Srinivasan K., Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Molecular and Cellular Biochemistry 1995 152 1 13 21 2-s2.0-0028807262
41. Babu P. S., Srinivasan K., Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Molecular and Cellular Biochemistry 1997 166 1-2 169 175 2-s2.0-8044223405 10.1023/A:1006819605211 (Pubitemid 27085099)
42. Kuroda M., Mimaki Y., Nishiyama T., Mae T., Kishida H., Tsukagawa M., Takahashi K., Kawada T., Nakagawa K., Kitahara M., Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biological and Pharmaceutical Bulletin 2005 28 5 937 939 2-s2.0-21144442930 10.1248/bpb.28.937 (Pubitemid 40740674)
43. Deng T., Sieglaff D. H., Zhang A., Lyon C. J., Ayers S. D., Cvoro A., Gupte A. A., Xia X., Baxter J. D., Webb P., Hsueh W. A., A peroxisome proliferator-activated receptor γ (PPAR γ)/ PPAR γ coactivator 1 β autoregulatory loop in adipocyte mitochondrial function. The Journal of Biological Chemistry 2011 286 35 30723 30731 2-s2.0-80052213436 10.1074/jbc.M111.251926
44. Schultze S. M., Hemmings B. A., Niessen M., Tschopp O., PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Reviews in Molecular Medicine 2012 14 e1 2-s2.0-84859057520 10.1017/S1462399411002109
45. Franckhauser S., Muñoz S., Elias I., Ferre T., Bosch F., Adipose overexpression of phosphoenolpyruvate carboxykinase leads to high susceptibility to diet-induced insulin resistance and obesity. Diabetes 2006 55 2 273 280 2-s2.0-33644764960 10.2337/diabetes.55.02.06.db05-0482 (Pubitemid 43343253)
46. Kim T., Davis J., Zhang A. J., He X., Mathews S. T., Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochemical and Biophysical Research Communications 2009 388 2 377 382 2-s2.0-69249216362 10.1016/j.bbrc.2009.08.018
47. Fujiwara H., Hosokawa M., Zhou X., Fujimoto S., Fukuda K., Toyoda K., Nishi Y., Fujita Y., Yamada K., Yamada Y., Seino Y., Inagaki N., Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Research and Clinical Practice 2008 80 2 185 191 2-s2.0-41749104639 10.1016/j.diabres.2007. 12.004
48. Tang Y., Chen A., Curcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids. Endocrinology 2010 151 9 4168 4177 2-s2.0-77956030796 10.1210/en.2010-0191
49. Lin J., Chen A., Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Molecular and Cellular Endocrinology 2011 333 2 160 171 2-s2.0-79651474066 10.1016/j.mce.2010.12.028
50. Lin J., Tang Y., Kang Q., Feng Y., Chen A., Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARgamma activity and attenuating oxidative stress. British Journal of Pharmacology 2012 166 8 2212 2227
51. Kang Q., Chen A., Curcumin eliminates oxidized LDL roles in activating hepatic stellate cells by suppressing gene expression of lectin-like oxidized LDL receptor-1. Laboratory Investigation 2009 89 11 1275 1290 2-s2.0-70350662973 10.1038/labinvest.2009.93
52. Lin J., Zheng S., Chen A., Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress. Laboratory Investigation 2009 89 12 1397 1409 2-s2.0-70549101361 10.1038/labinvest.2009.115
53. Gustafson B., Smith U., Cytokines promote Wnt signaling and inflammation and impair the normal differentiation and lipid accumulation in 3T3-L1 preadipocytes. The Journal of Biological Chemistry 2006 281 14 9507 9516 2-s2.0-33646934768 10.1074/jbc.M512077200 (Pubitemid 43864668)
54. Hegarty B. D., Furler S. M., Ye J., Cooney G. J., Kraegen E. W., The role of intramuscular lipid in insulin resistance. Acta Physiologica Scandinavica 2003 178 4 373 383 2-s2.0-0042160182 10.1046/j.1365-201X.2003.01162.x (Pubitemid 36960428)
55. Xie X. Y., Kong P. R., Wu J. F., Li Y., Li Y. X., Curcumin attenuates lipolysis stimulated by tumor necrosis factor-alpha or isoproterenol in 3T-L1 adipocytes. Phytomedicine 2012 20 1 3 8
56. Oner-Iyidogan Y., Kocak H., Seyidhanoglu M., Gurdol F., Gulcubuk A., Yildirim F., Cevik A., Uysal M., Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet. Journal of Physiology and Biochemistry 2013 10.1007/s13105-013-0244-9
57. Haukeland J. W., Dahl T. B., Yndestad A., Gladhaug I. P., Løberg E. M., Haaland T., Konopski Z., Wium C., Aasheim E. T., Johansen O. E., Aukrust P., Halvorsen B., Birkeland K. I., Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies. European Journal of Endocrinology 2012 166 3 503 510 2-s2.0-84857926081 10.1530/EJE-11-0864
58. Stefan N., Hennige A. M., Staiger H., Machann J., Schick F., Kröber S. M., Machicao F., Fritsche A., Häring H.-U., α 2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006 29 4 853 857 2-s2.0-33746367157 (Pubitemid 44115306)
59. Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F. D., Kresno S. B., Ernie S., The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta medica Indonesiana 2008 40 4 201 210 2-s2.0-67651206071
60. Guilherme A., Virbasius J. V., Puri V., Czech M. P., Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nature Reviews Molecular Cell Biology 2008 9 5 367 377 2-s2.0-42449097289 10.1038/nrm2391 (Pubitemid 351574198)
61. Woo H.-M., Kang J.-H., Kawada T., Yoo H., Sung M.-K., Yu R., Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes. Life Sciences 2007 80 10 926 931 2-s2.0-33846565847 10.1016/j.lfs.2006.11.030 (Pubitemid 46186427)
62. Ohara K., Uchida A., Nagasaka R., Ushio H., Ohshima T., The effects of hydroxycinnamic acid derivatives on adiponectin secretion. Phytomedicine 2009 16 2-3 130 137 2-s2.0-59649094972 10.1016/j.phymed.2008.09.012
63. Gonzales A. M., Orlando R. A., Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutrition & Metabolism 2008 5 1, article 17 2-s2.0-46149101224 10.1186/1743-7075-5-17 (Pubitemid 351904902)
64. Ahn J., Lee H., Kim S., Ha T., Curcumin-induced suppression of adipogenic differentiation is accompanied by activation of Wnt/ β -catenin signaling. American Journal of Physiology 2010 298 6 C1510 C1516 2-s2.0-77952613059 10.1152/ajpcell.00369.2009
65. He T.-C., Sparks A. B., Rago C., Hermeking H., Zawel L., Da Costa L. T., Morin P. J., Vogelstein B., Kinzler K. W., Identification of c-MYC as a target of the APC pathway. Science 1998 281 5382 1509 1512 2-s2.0-0032483439 10.1126/science.281.5382.1509 (Pubitemid 28425575)
66. Tetsu O., McCormick F., β -catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999 398 6726 422 426 2-s2.0-0033119801 10.1038/18884 (Pubitemid 29180374)
67. Ninomiya-Tsuji J., Torti F. M., Ringold G. M., Tumor necrosis factor-induced c-myc expression in the absence of mitogenesis is associated with inhibition of adipocyte differentiation. Proceedings of the National Academy of Sciences of the United States of America 1993 90 20 9611 9615 2-s2.0-0027491022 10.1073/pnas.90.20.9611 (Pubitemid 23315835)
68. Fu M., Rao M., Bouras T., Wang C., Wu K., Zhang X., Li Z., Yao T.-P., Pestell R. G., Cyclin D1 inhibits peroxisome proliferator-activated receptor γ -mediated adipogenesis through histone deacetylase recruitment. The Journal of Biological Chemistry 2005 280 17 16934 16941 2-s2.0-20444439929 10.1074/jbc.M500403200 (Pubitemid 41389153)
69. Joshi R. P., Negi G., Kumar A., Pawar Y. B., Munjal B., Bansal A. K., Sharma S. S., SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine 2013 9 6 776 785 10.1016/j.nano.2013.01.001
70. Kumar P. A., Suryanarayana P., Reddy P. Y., Reddy G. B., Modulation of α -crystallin chaperone activity in diabetic rat lens by curcumin. Molecular Vision 2005 11 561 568 2-s2.0-26244442494 (Pubitemid 41410220)
71. Kumar P. A., Haseeb A., Suryanarayana P., Ehtesham N. Z., Reddy G. B., Elevated expression of α A- and α B-crystallins in streptozotocin-induced diabetic rat. Archives of Biochemistry and Biophysics 2005 444 2 77 83 2-s2.0-28444468107 10.1016/j.abb.2005.09.021 (Pubitemid 41728339)
72. Kase S., Ishida S., Rao N. A., Increased expression of α A-crystallin in human diabetic eye. International Journal of Molecular Medicine 2011 28 4 505 511 2-s2.0-79960765391 10.3892/ijmm.2011.708
73. Losiewicz M. K., Fort P. E., Diabetes impairs the neuroprotective properties of retinal alpha-crystallins. Investigative Ophthalmology & Visual Science 2011 52 9 5034 5042 2-s2.0-80054788049
74. Suryanarayana P., Saraswat M., Mrudula T., Krishna T. P., Krishnaswamy K., Reddy G. B., Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Investigative Ophthalmology and Visual Science 2005 46 6 2092 2099 2-s2.0-22144432295 10.1167/iovs.04-1304
75. Premanand C., Rema M., Sameer M. Z., Sujatha M., Balasubramanyam M., Effect of curcumin on proliferation of human retinal endothelial cells under in vitro conditions. Investigative Ophthalmology and Visual Science 2006 47 5 2179 2184 2-s2.0-33744734628 10.1167/iovs.05-0580 (Pubitemid 46768303)
76. Sameermahmood Z., Balasubramanyam M., Saravanan T., Rema M., Curcumin modulates SDF-1 α /CXCR4-induced migration of human retinal endothelial cells (HRECs). Investigative Ophthalmology and Visual Science 2008 49 8 3305 3311 2-s2.0-49049102116 10.1167/iovs.07-0456
77. Gupta S. K., Kumar B., Nag T. C., Agrawal S. S., Agrawal R., Agrawal P., Saxena R., Srivastava S., Curcumin prevents experimental diabetic retinopathy in rats through its hypoglycemic, antioxidant, and anti-inflammatory mechanisms. Journal of Ocular Pharmacology and Therapeutics 2011 27 2 123 130 2-s2.0-79955008744 10.1089/jop.2010.0123
78. Mrudula T., Suryanarayana P., Srinivas P. N. B. S., Reddy G. B., Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochemical and Biophysical Research Communications 2007 361 2 528 532 2-s2.0-34547505136 10.1016/j.bbrc.2007.07.059 (Pubitemid 47187290)
79. Kowluru R. A., Kanwar M., Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutrition & Metabolism 2007 4, article 8 2-s2.0-34247542013 10.1186/1743-7075-4-8 (Pubitemid 46663082)
80. Wang C., George B., Chen S., Feng B., Li X., Chakrabarti S., Genotoxic stress and activation of novel DNA repair enzymes in human endothelial cells and in the retinas and kidneys of streptozotocin diabetic rats. Diabetes/Metabolism Research and Reviews 2012 28 4 329 337
81. Kuhad A., Chopra K., Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences. European Journal of Pharmacology 2007 576 1-3 34 42 2-s2.0-35348851411 10.1016/j.ejphar.2007.08.001 (Pubitemid 47588254)
82. Peeyush Kumar T., Antony S., Soman S., Kuruvilla K. P., George N., Paulose C. S., Role of curcumin in the prevention of cholinergic mediated cortical dysfunctions in streptozotocin-induced diabetic rats. Molecular and Cellular Endocrinology 2011 331 1 1 10 2-s2.0-78149403787 10.1016/j.mce.2010.07. 004
83. Kumar T. P., Antony S., Gireesh G., George N., Paulose C. S., Curcumin modulates dopaminergic receptor, CREB and phospholipase C gene expression in the cerebral cortex and cerebellum of streptozotocin induced diabetic rats. Journal of Biomedical Science 2010 17 43 2-s2.0-77956199213 10.1186/1423-0127-17-43
84. Kumar P. T., George N., Antony S., Skaria Paulose C., Curcumin restores diabetes induced neurochemical changes in the brain stem of Wistar rats. European Journal of Pharmacology 2013 702 1-3 323 331
85. Jayanarayanan S., Smijin S., Peeyush K. T., Anju T. R., Paulose C. S., NMDA and AMPA receptor mediated excitotoxicity in cerebral cortex of streptozotocin induced diabetic rat: ameliorating effects of curcumin. Chemico-Biological Interactions 2013 201 1-3 39 48
86. Wang X., Song Y., Chen L., Zhuang G., Zhang J., Li M., Meng X. F., Contribution of single-minded 2 to hyperglycaemia-induced neurotoxicity. Neurotoxicology 2013 35 106 112
87. Ma Q.-L., Yang F., Rosario E. R., Ubeda O. J., Beech W., Gant D. J., Ping P. C., Hudspeth B., Chen C., Zhao Y., Vinters H. V., Frautschy S. A., Cole G. M., β -Amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin. Journal of Neuroscience 2009 29 28 9078 9089 2-s2.0-67650729973 10.1523/JNEUROSCI.1071-09.2009
88. Sharma S., Kulkarni S. K., Agrewala J. N., Chopra K., Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. European Journal of Pharmacology 2006 536 3 256 261 2-s2.0-33646032364 10.1016/j.ejphar.2006.03.006
89. Attia H. N., Al-Rasheed N. M., Al-Rasheed N. M., Maklad Y. A., Ahmed A. A. E., Kenawy S. A. B., Protective effects of combined therapy of gliclazide with curcumin in experimental diabetic neuropathy in rats. Behavioural Pharmacology 2012 23 2 153 161 2-s2.0-84858680957 10.1097/FBP.0b013e3283512c00
90. Li Y., Zhang Y., Liu D. B., Liu H. Y., Hou W. G., Dong Y. S., Curcumin attenuates diabetic neuropathic pain by downregulating TNF- α in a rat model. International Journal of Medical Sciences 2013 10 4 377 381 10.7150/ijms.5224
91. Sharma S., Chopra K., Kulkarni S. K., Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha. Phytotherapy Research 2007 21 3 278 283 2-s2.0-33947579407 10.1002/ptr.2070 (Pubitemid 46479679)
92. Acar A., Akil E., Alp H., Evliyaoglu O., Kibrisli E., Inal A., Unan F., Tasdemir N., Oxidative damage is ameliorated by curcumin treatment in brain and sciatic nerve of diabetic rats. The International Journal of Neuroscience 2012 122 7 367 372
93. Maric-Bilkan C., Obesity and diabetic kidney disease. The Medical Clinics of North America 2013 97 1 59 74
94. Reutens A. T., Epidemiology of diabetic kidney disease. The Medical Clinics of North America 2013 97 1 1 18
95. Tikoo K., Meena R. L., Kabra D. G., Gaikwad A. B., Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy. British Journal of Pharmacology 2008 153 6 1225 1231 2-s2.0-40949119020 10.1038/sj.bjp.0707666 (Pubitemid 351415498)
96. Sharma S., Kulkarni S. K., Chopra K., Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clinical and Experimental Pharmacology and Physiology 2006 33 10 940 945 2-s2.0-33748891024 10.1111/j.1440-1681.2006.04468.x (Pubitemid 44427317)
97. Babu P. S., Srinivasan K., Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Molecular and Cellular Biochemistry 1998 181 1-2 87 96 2-s2.0-0031883154 10.1023/A: 1006821828706 (Pubitemid 28127781)
98. Chiu J., Khan Z. A., Farhangkhoee H., Chakrabarti S., Curcumin prevents diabetes-associated abnormalities in the kidneys by inhibiting p300 and nuclear factor- B. Nutrition 2009 25 9 964 972 2-s2.0-67651182607 10.1016/j.nut.2008.12. 007
99. Ma J., Phillips L., Wang Y., Dai T., LaPage J., Natarajan R., Adler S. G., Curcumin activates the p38MPAK-HSP25 pathway in vitro but fails to attenuate diabetic nephropathy in DBA2J mice despite urinary clearance documented by HPLC. BMC Complementary and Alternative Medicine 2010 10, article 67 2-s2.0-78149310718 10.1186/1472-6882-10-67
100. Soetikno V., Sari F. R., Sukumaran V., Lakshmanan A. P., Harima M., Suzuki K., Kawachi H., Watanabe K., Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats. The Journal of Nutritional Biochemistry 2013 24 5 796 802
101. Sawatpanich T., Petpiboolthai H., Punyarachun B., Anupunpisit V., Effect of curcumin on vascular endothelial growth factor expression in diabetic mice kidney induced by streptozotocin. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet 2010 93 S1 S8 2-s2.0-79952274286
102. Khajehdehi P., Pakfetrat M., Javidnia K., Azad F., Malekmakan L., Nasab M. H., Dehghanzadeh G., Oral supplementation of turmeric attenuates proteinuria, transforming growth factor- β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Scandinavian Journal of Urology and Nephrology 2011 45 5 365 370 2-s2.0-80054052195 10.3109/00365599.2011.585622
103. Soetikno V., Sari F. R., Sukumaran V., Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway. European Journal of Pharmaceutical Sciences 2012 47 3 604 614
104. Feng B., Chen S., Chiu J., George B., Chakrabarti S., Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level. American Journal of Physiology 2008 294 6 E1119 E1126 2-s2.0-47549102245 10.1152/ajpendo.00029.2008
105. Sajithlal G. B., Chithra P., Chandrakasan G., Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochemical Pharmacology 1998 56 12 1607 1614 2-s2.0-0031774992 10.1016/S0006-2952(98)00237- 8 (Pubitemid 28561480)
106. Okamoto T., Yamagishi S.-I., Inagaki Y., Amano S., Koga K., Abe R., Takeuchi M., Ohno S., Yoshimura A., Makita Z., Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. The FASEB Journal 2002 16 14 1928 1930 2-s2.0-0036884617
107. Farhangkhoee H., Khan Z. A., Chen S., Chakrabarti S., Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutrition & Metabolism 2006 3, article 27 2-s2.0-33747344675 10.1186/1743-7075-3-27
108. Srivastava G., Mehta J. L., Currying the heart: curcumin and cardioprotection. Journal of Cardiovascular Pharmacology and Therapeutics 2009 14 1 22 27 2-s2.0-61449133232 10.1177/1074248408329608
109. Rungseesantivanon S., Thenchaisri N., Ruangvejvorachai P., Patumraj S., Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complementary and Alternative Medicine 2010 10, article 57 2-s2.0-77957765255 10.1186/1472-6882-10-57
110. Sidhu G. S., Mani H., Gaddipati J. P., Singh A. K., Seth P., Banaudha K. K., Patnaik G. K., Maheshwari R. K., Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair and Regeneration 1999 7 5 362 374 2-s2.0-0032744537 10.1046/j.1524-475X.1999. 00362.x (Pubitemid 29523012)
111. Singh N., Ranjan V., Zaidi D., Shyam H., Singh A., Lodha D., Sharma R., Verma U., Dixit J., Balapure A. K., Insulin catalyzes the curcumin-induced wound healing: an in vitro model for gingival repair. Indian Journal of Pharmacology 2012 44 4 458 462
112. Merrell J. G., McLaughlin S. W., Tie L., Laurencin C. T., Chen A. F., Nair L. S., Curcumin-loaded poly(ε -caprolactone) nanofibres: diabetic wound dressing with anti-oxidant and anti-inflammatory properties. Clinical and Experimental Pharmacology and Physiology 2009 36 12 1149 1156 2-s2.0-72149099632 10.1111/j.1440-1681.2009.05216.x
113. Elosta A., Ghous T., Ahmed N., Natural products as Anti-glycation agents: possible therapeutic potential for diabetic complications. Current Diabetes Reviews 2012 8 2 92 108 2-s2.0-84857720782 10.2174/157339912799424528
114. Hu T. Y., Liu C. L., Chyau C. C., Hu M. L., Trapping of methylglyoxal by curcumin in cell-free systems and in human umbilical vein endothelial cells. Journal of Agricultural and Food Chemistry 2012 60 33 8190 8196
115. Choi K.-H., Park J.-W., Kim H.-Y., Kim Y.-H., Kim S.-M., Son Y.-H., Park Y.-C., Eo S.-K., Kim K., Cellular factors involved in CXCL8 expression induced by glycated serum albumin in vascular smooth muscle cells. Atherosclerosis 2010 209 1 58 65 2-s2.0-77049095582 10.1016/j.atherosclerosis.2009.08.030
116. Rungseesantivanon S., Thengchaisri N., Ruangvejvorachai P., Patumraj S., Curcumin improves prostanoid ratio in diabetic mesenteric arteries associated with cyclooxygenase-2 and NF- B suppression. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2010 3 421 429 10.2147/DMSOTT.S14882
117. Hassan N., El-Bassossy H. M., Zakaria M. N., Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility. Naunyn-Schmiedeberg's Archives of Pharmacology 2013 386 3 217 226
118. Ndisang J. F., Jadhav A., Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. American Journal of Physiology 2009 296 4 E829 E841 2-s2.0-65649110522 10.1152/ajpendo.90783.2008
119. Ndisang J. F., Jadhav A., The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. American Journal of Physiology 2010 298 1 R211 R223 2-s2.0-73549113296 10.1152/ajpregu.91000.2008
120. Khimmaktong W., Petpiboolthai H., Panyarachun B., Anupunpisit V., Study of curcumin on microvasculature characteristic in diabetic rat's liver as revealed by vascular corrosion cast/scanning electron microscope (SEM) technique. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet 2012 95 supplement 5 S133 S141
121. Appendino G., Belcaro G., Cornelli U., Luzzi R., Togni S., Dugall M., Cesarone M. R., Feragalli B., Ippolito E., Errichi B. M., Pellegrini L., Ledda A., Ricci A., Bavera P., Hosoi M., Stuard S., Corsi M., Errichi S., Gizzi G., Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Medica 2011 53 3 43 49 2-s2.0-84859470499
122. Steigerwalt R., Nebbioso M., Appendino G., Meriva, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy. Panminerva Medica 2012 54 1, supplement 4 11 16
123. Li L., Sawamura T., Renier G., Glucose enhances human macrophage LOX-1
124. Jain S. K., Rains J., Jones K., Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free Radical Biology and Medicine 2006 41 1 92 96 2-s2.0-33744979960 10.1016/j.freeradbiomed.2006.03.008 (Pubitemid 43866454)
125. Muthenna P., Suryanarayana P., Gunda S. K., Petrash J. M., Reddy G. B., Inhibition of aldose reductase by dietary antioxidant curcumin: mechanism of inhibition, specificity and significance. FEBS Letters 2009 583 22 3637 3642 2-s2.0-71749083155 10.1016/j.febslet.2009.10.042
126. Pantazis P., Varman A., Simpson-Durand C., Thorpe J., Ramalingam S., Subramaniam D., Houchen C., Ihnat M., Anant S., Ramanujam R. P., Curcumin and turmeric attenuate arsenic-induced angiogenesis in ovo. Alternative Therapies in Health and Medicine 2010 16 2 12 14 2-s2.0-77951214509
127. Hie M., Yamazaki M., Tsukamoto I., Curcumin suppresses increased bone resorption by inhibiting osteoclastogenesis in rats with streptozotocin-induced diabetes. European Journal of Pharmacology 2009 621 1-3 1 9 2-s2.0-70349515164 10.1016/j.ejphar.2009.08.025
128. Cheng T.-C., Lin C.-S., Hsu C.-C., Chen L.-J., Cheng K.-C., Cheng J.-T., Activation of muscarinic M-1 cholinoceptors by curcumin to increase glucose uptake into skeletal muscle isolated from Wistar rats. Neuroscience Letters 2009 465 3 238 241 2-s2.0-70349782206 10.1016/j.neulet.2009.09.012
129. Deng Y.-T., Chang T.-W., Lee M.-S., Lin J.-K., Suppression of free fatty acid-induced insulin resistance by phytopolyphenols in C2C12 mouse skeletal muscle cells. Journal of Agricultural and Food Chemistry 2012 60 4 1059 1066 2-s2.0-84856538392 10.1021/jf204496f
130. Abdel Aziz M. T., Motawi T., Rezq A., Mostafa T., Fouad H. H., Ahmed H. H., Rashed L., Sabry D., Senbel A., Al-Malki A., El-Shafiey R., Effects of a water-soluble curcumin protein conjugate vs. pure curcumin in a diabetic model of erectile dysfunction. Journal of Sexual Medicine 2012 9 7 1815 1833 2-s2.0-84860356042 10.1111/j.1743-6109.2012.02741.x
131. Kanter M., Aktas C., Erboga M., Curcumin attenuates testicular damage, apoptotic germ cell death, and oxidative stress in streptozotocin-induced diabetic rats. Molecular Nutrition & Food Research 2012 57 9 1578 1585 10.1002/mnfr.201200170
132. Jin Q. H., Shen H. X., Wang H., Shou Q. Y., Liu Q., Curcumin improves expression of SCF/c-kit through attenuating oxidative stress and NF- B activation in gastric tissues of diabetic gastroparesis rats. Diabetology & Metabolic Syndrome 2013 5 1 12 10.1186/1758-5996-5-12
133. Iwasaki H., Kajimura M., Osawa S., Kanaoka S., Furuta T., Ikuma M., Hishida A., A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. Journal of Gastroenterology 2006 41 11 1076 1087 2-s2.0-33845420362 10.1007/s00535-006-1909-8 (Pubitemid 44896722)
134. Giacco F., Brownlee M., Oxidative stress and diabetic complications. Circulation Research 2010 107 9 1058 1070 2-s2.0-78349297565 10.1161/CIRCRESAHA.110.223545
135. Gururajan M., Dasu T., Shahidain S., Jennings C. D., Robertson D. A., Rangnekar V. M., Bondada S., Spleen tyrosine kinase (Syk), a novel target of curcumin, is required for B lymphoma growth. Journal of Immunology 2007 178 1 111 121 2-s2.0-33845927271 (Pubitemid 46033592)
136. Meghana K., Sanjeev G., Ramesh B., Curcumin prevents streptozotocin- induced islet damage by scavenging free radicals: a prophylactic and protective role. European Journal of Pharmacology 2007 577 1-3 183 191 2-s2.0-35448932469 10.1016/j.ejphar.2007.09.002 (Pubitemid 47632529)
137. Kanitkar M., Gokhale K., Galande S., Bhonde R. R., Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. British Journal of Pharmacology 2008 155 5 702 713 2-s2.0-54949151846 10.1038/bjp.2008.311
138. Kanitkar M., Bhonde R. R., Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation. Life Sciences 2008 82 3-4 182 189 2-s2.0-37549011770 10.1016/j.lfs.2007.10.026
139. Chanpoo M., Petchpiboonthai H., Panyarachun B., Anupunpisit V., Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice. Journal of the Medical Association of Thailand = Chotmaihet Thangphaet 2010 93 S152 159 2-s2.0-84855494579
140. Zafar K. S., Inayat-Hussain S. H., Siegel D., Bao A., Shieh B., Ross D., Overexpression of NQO1 protects human SK-N-MC neuroblastoma cells against dopamine-induced cell death. Toxicology Letters 2006 166 3 261 267 2-s2.0-33748772788 10.1016/j.toxlet.2006.07.340 (Pubitemid 44416555)
141. Balamurugan A. N., Akhov L., Selvaraj G., Pugazhenthi S., Induction of antioxidant enzymes by curcumin and its analogues in human islets: implications in transplantation. Pancreas 2009 38 4 454 460 10.1097/MPA.0b013e318196c3e7
142. Best L., Elliott A. C., Brown P. D., Curcumin induces electrical activity in rat pancreatic β -cells by activating the volume-regulated anion channel. Biochemical Pharmacology 2007 73 11 1768 1775 2-s2.0-34247125729 10.1016/j.bcp.2007.02.006 (Pubitemid 46601410)
143. Khalooghi K., Hashemi S., Mehraban N., Amiri P., Bazzaz J. T., Larijani B., Amoli M. M., In vitro modulation of TCF7L2 gene expression in human pancreatic cells. Molecular Biology Reports 2009 36 8 2329 2332 2-s2.0-70350303287 10.1007/s11033-009-9452-3
144. Yan Y., Klein R., Heiss G., Girman C. J., Lange E. M., Klein B. E., Rose K. M., Boerwinkle E., Pankow J. S., Brancati F. L., Ballantyne C. M., Köttgen A., North K. E., The transcription factor 7-like 2 (TCF7L2) polymorphism may be associated with focal arteriolar narrowing in Caucasians with hypertension or without diabetes: the ARIC Study. BMC Endocrine Disorders 2010 10, article 9 2-s2.0-77952159555 10.1186/1472-6823-10-9
145. Ran C., Zhao W., Moir R. D., Moore A., Non-conjugated small molecule FRET for differentiating monomers from higher molecular weight amyloid beta species. PLoS ONE 2011 6 4 2-s2.0-79955765954 10.1371/journal.pone.0019362 e19362
146. Daval M., Bedrood S., Gurlo T., Huang C.-J., Costes S., Butler P. C., Langen R., The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity. Amyloid 2010 17 3-4 118 128 2-s2.0-78649301065 10.3109/13506129.2010.530008
147. Sparks S., Liu G., Robbins K. J., Lazo N. D., Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling alpha-helix. Biochemical and Biophysical Research Communications 2012 422 4 551 555
148. Cai K., Qi D., Hou X., Wang O., Chen J., Deng B., Qian L., Liu X., Le Y., MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF- B related signaling pathways independent of CCR2. PLoS ONE 2011 6 5 2-s2.0-79955895603 10.1371/journal.pone.0019559 e19559
149. Xie W., Du L., Diabetes is an inflammatory disease: evidence from traditional Chinese medicines. Diabetes, Obesity and Metabolism 2011 13 4 289 301 2-s2.0-79951931336 10.1111/j.1463-1326.2010.01336.x
150. Jagetia G. C., Aggarwal B. B., "Spicing up" of the immune system by curcumin. Journal of Clinical Immunology 2007 27 1 19 35 2-s2.0-33846889718 10.1007/s10875-006-9066-7 (Pubitemid 46224931)
151. Margina D., Gradinaru D., Manda G., Neagoe I., Ilie M., Membranar effects exerted in vitro by polyphenols-quercetin, epigallocatechin gallate and curcumin-on HUVEC and Jurkat cells, relevant for diabetes mellitus. Food and Chemical Toxicology 2013 10.1016/j.fct.2013.02.046
152. Sharma S., Chopra K., Kulkarni S. K., Agrewala J. N., Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clinical and Experimental Immunology 2007 147 1 155 163 2-s2.0-33845496809 10.1111/j.1365-2249.2006.03257.x (Pubitemid 44915567)
153. Yun J.-M., Jialal I., Devaraj S., Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. Journal of Nutritional Biochemistry 2011 22 5 450 458 2-s2.0-79954602833 10.1016/j.jnutbio.2010.03.014
154. Pham T. X., Lee J., Dietary regulation of histone acetylases and deacetylases for the prevention of metabolic diseases. Nutrients 2012 4 12 1868 1886
155. Yekollu S. K., Thomas R., O'Sullivan B., Targeting curcusomes to inflammatory dendritic cells inhibits NF- B and improves insulin resistance in obese mice. Diabetes 2011 60 11 2928 2938 2-s2.0-80755184694 10.2337/db11-0275
156. Balasubramanyam M., Koteswari A. A., Kumar R. S., Monickaraj S. F., Maheswari J. U., Mohan V., Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. Journal of Biosciences 2003 28 6 715 721 2-s2.0-0346243915 (Pubitemid 37522778)
157. Hsuuw Y.-D., Chang C.-K., Chan W.-H., Yu J.-S., Curcumin prevents methylglyoxal-induced oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts. Journal of Cellular Physiology 2005 205 3 379 386 2-s2.0-21344462243 10.1002/jcp.20408 (Pubitemid 41598852)
158. Chan W.-H., Wu H.-J., Hsuuw Y.-D., Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Annals of the New York Academy of Sciences 2005 1042 372 378 2-s2.0-22044441361 10.1196/annals.1338.057 (Pubitemid 40967659)
159. Mahesh T., Balasubashini M. S., Menon V. P., Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. Journal of Medicinal Food 2005 8 2 251 255 2-s2.0-22444450989 10.1089/jmf.2005.8.251 (Pubitemid 41008991)
160. Fan X., Zhang C., Liu D. B., Yan J., Liang H. P., The clinical applications of curcumin: current state and the future. Current Pharmaceutical Design 2013 19 11 2011 2031
161. Yang C. S., Sang S., Lambert J. D., Lee M.-J., Bioavailability issues in studying the health effects of plant polyphenolic compounds. Molecular Nutrition and Food Research 2008 52 1 S139 S151 2-s2.0-53449089371 10.1002/mnfr.200700234
162. Anand P., Thomas S. G., Kunnumakkara A. B., Sundaram C., Harikumar K. B., Sung B., Tharakan S. T., Misra K., Priyadarsini I. K., Rajasekharan K. N., Aggarwal B. B., Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochemical Pharmacology 2008 76 11 1590 1611 2-s2.0-55949084512 10.1016/j.bcp.2008.08.008
163. Gupta S. C., Patchva S., Aggarwal B. B., Therapeutic roles of curcumin: lessons learned from clinical trials. The AAPS Journal 2013 15 1 195 218
164. Abdel Aziz M. T., El-Asmar M. F., El-Ibrashy I. N., Effect of novel water soluble curcumin derivative on experimental type-1 diabetes mellitus (short term study). Diabetology & Metabolic Syndrome 2012 4 1 30
165. Rastogi M., Ojha R., Rajamanickam G. V., Agrawal A., Aggarwal A., Dubey G. P., Curcuminoids modulates oxidative damage and mitochondrial dysfunction in diabetic rat brain. Free Radical Research 2008 42 11-12 999 1005 2-s2.0-57649207993 10.1080/10715760802571988
166. Pugazhenthi S., Akhov L., Selvaraj G., Wang M., Alam J., Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse β -cells. American Journal of Physiology 2007 293 3 E645 E655 2-s2.0-34548429119 10.1152/ajpendo.00111.2007 (Pubitemid 47358975)
167. Ponnusamy S., Zinjarde S., Bhargava S., Rajamohanan P. R., Ravikumar A., Discovering Bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic alpha-amylase, a target for type-2 diabetes. Food Chemistry 2012 135 4 2638 2642
168. Osawa T., Kato Y., Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Annals of the New York Academy of Sciences 2005 1043 440 451 2-s2.0-23744510724 10.1196/annals.1333.050 (Pubitemid 41123932)
169. Pari L., Murugan P., Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. Journal of Basic and Clinical Physiology and Pharmacology 2005 16 4 257 274 2-s2.0-30644469766 (Pubitemid 43089170)
170. Murugan P., Pari L., Antioxidant effect of tetrahydrocurcumin in streptozotocin-nicotinamide induced diabetic rats. Life Sciences 2006 79 18 1720 1728 2-s2.0-33748527750 10.1016/j.lfs.2006.06.001 (Pubitemid 44374550)
171. Murugan P., Pari L., Effect of tetrahydrocurcumin on plasma antioxidants in streptozotocin-nicotinamide experimental diabetes. Journal of Basic and Clinical Physiology and Pharmacology 2006 17 4 231 244 2-s2.0-33847229866
172. Murugan P., Pari L., Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats. Basic and Clinical Pharmacology and Toxicology 2006 99 2 122 127 2-s2.0-33747128555 10.1111/j.1742-7843.2006.pto-447.x (Pubitemid 44218530)
173. Pari L., Murugan P., Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Renal Failure 2007 29 7 881 889 2-s2.0-36248994780 10.1080/08860220701540326 (Pubitemid 350130069)
174. Pari L., Murugan P., Changes in glycoprotein components in streptozotocin-nicotinamide induced type 2 diabetes: influence of tetrahydrocurcumin from Curcuma longa. Plant Foods for Human Nutrition 2007 62 1 25 29 2-s2.0-33847284544 10.1007/s11130-006-0037-1 (Pubitemid 46327409)
175. Murugan P., Pari L., Rao C. A., Effect of tetrahydrocurcumin on insulin receptor status in type 2 diabetic rats: studies on insulin binding to erythrocytes. Journal of Biosciences 2008 33 1 63 72 2-s2.0-41649118944 10.1007/s12038-008-0022-y (Pubitemid 351481880)
176. Pari L., Murugan P., Influence of tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin-nicotinamide- induced type 2 diabetes. Fundamental and Clinical Pharmacology 2007 21 6 665 671 2-s2.0-36349011823 10.1111/j.1472-8206.2007.00542.x (Pubitemid 350151253)
177. Pari L., Karthikesan K., Menon V. P., Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Molecular and Cellular Biochemistry 2010 341 1-2 109 117 2-s2.0-77955012675 10.1007/s11010-010-0442-5
178. Karthikesan K., Pari L., Menon V. P., Combined treatment of tetrahydrocurcumin and chlorogenic acid exerts potential antihyperglycemic effect on streptozotocin-nicotinamide-induced diabetic rats. General Physiology and Biophysics 2010 29 1 23 30 2-s2.0-77952047804 10.4149/gpb-2010-01-23
179. Reddy B. V., Sundari J. S., Balamurugan E., Menon V. P., Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats. Molecular and Cellular Biochemistry 2009 331 1-2 127 133 2-s2.0-74049094104 10.1007/s11010-009-0150-1
180. Reddy B. V., Sivagama Sundari J., Balamurugan E., Menon V. P., Antihyperlipidemic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5- dione, a curcumin analog, on nicotine and streptozotocin treated rats. Molecular and Cellular Biochemistry 2010 335 1-2 249 254 2-s2.0-75949093247 10.1007/s11010-009-0274-3
181. Srinivasan A., Menon V. P., Periaswamy V., Rajasekaran K. N., Protection of pancreatic β -cell by the potential antioxidant bis-o-hydroxycinnamoyl methane, analogue of natural curcuminoid in experimental diabetes. Journal of Pharmacy & Pharmaceutical Sciences 2003 6 3 327 333 2-s2.0-0347300712 (Pubitemid 38097546)
182. Majithiya J. B., Balaraman R., Giridhar R., Yadav M. R., Effect of bis[curcumino]oxovanadium complex on non-diabetic and streptozotocin-induced diabetic rats. Journal of Trace Elements in Medicine and Biology 2005 18 3 211 217 2-s2.0-18044397497 10.1016/j.jtemb.2004.12.001 (Pubitemid 40603299)
183. Pan Y., Wang Y., Cai L., Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats. British Journal of Pharmacology 2012 166 3 1169 1182
184. Pan Y., Zhu G., Wang Y., Attenuation of high-glucose-induced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart. The Journal of Nutritional Biochemistry 2013 24 1 146 155
185. Usharani P., Mateen A. A., Naidu M. U. R., Raju Y. S. N., Chandra N., Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs in R&D 2008 9 4 243 250 2-s2.0-46349109182 10.2165/00126839-200809040-00004 (Pubitemid 351920123)